Stable, metastable, and kinetically trapped amyloid aggregate phases

Biomacromolecules

Volumn 16, Issue 1, 2015, Pages 326-335

  Miti, Tatiana ^a   Mulaj, Mentor ^a   Schmit, Jeremy D ^b   Muschol, Martin ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; AGGREGATES; GLYCOPROTEINS; LIQUIDS; METASTABLE PHASES; NEURODEGENERATIVE DISEASES; OLIGOMERS; PHASE SEPARATION; SELF ASSEMBLY;

ALZHEIMER'S DISEASE; AMYLOID FORMATION; DIFFERENT STRUCTURE; METASTABLE LIQUID; MOLECULAR ENTITIES; NUCLEATION AND GROWTH; PROTEIN CONCENTRATIONS; SURFACTANT AGGREGATION;

PROTEINS;

AMYLOID; LYSOZYME; MONOMER; OLIGOMER; SODIUM CHLORIDE;

ANISOTROPY; ARTICLE; ATOMIC FORCE MICROSCOPY; CRITICAL MICELLE CONCENTRATION; ENERGY; ENERGY COST; FIBER; INFRARED SPECTROSCOPY; IONIC STRENGTH; KINETICS; OLIGOMERIZATION; PHASE SEPARATION; POLYMERIZATION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STABILITY; STATIC ELECTRICITY; SURFACE CHARGE; THERMODYNAMICS; CHEMICAL MODEL; CHEMISTRY; HUMAN; METABOLISM; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SALINITY;

AMYLOID; HUMANS; MICROSCOPY, ATOMIC FORCE; MODELS, CHEMICAL; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; SALINITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84921046821     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm501521r     Document Type: Article

References (57)

1. Kelly, J. W. Alternative Conformations of Amyloidogenic Proteins Govern Their Behavior. Curr. Opin. Struct. Biol. 1996, 6, 11-17.
2. Chiti, F.; Dobson, C. M. Protein Misfolding, Functional Amyloid, and Human Disease. Annu. Rev. Biochem. 2006, 75, 333-366.
3. Dobson, C. M. Protein Misfolding, Evolution, and Disease. Trends Biochem. Sci. 1999, 24, 329-332.
4. Jain, N.; Bhattacharya, M.; Mukhopadhyay, S. Chain Collapse of an Amyloidogenic Intrinsically Disordered Protein. Biophys. J. 2011, 101, 1720-1729.
5. Gosal, W. S.; Clark, A. H.; Pudney, P. D. A.; Ross-Murphy, S. B. Novel Amyloid Fibrillar Networks Derived from a Globular Protein: β-Langmuir 2002, 18, 7174-7181.
6. Holm, N. K.; Jespersen, S. K.; Thomassen, L. V.; Wolff, T. Y.; Sehgal, P.; Thomsen, L. A.; Christiansen, G.; Andersen, C. B.; Knudsen, A. D.; Otzen, D. E. Aggregation and Fibrillation of Bovine Serum Albumin. Biochim. Biophys. Acta, Proteins Proteomics 2007, 1774, 1128-1138.
7. Bromley, E. H. C.; Krebs, M. R. H.; Donald, A. M. Aggregation Across the Length-Scales in β-Lactoglobulin. Faraday Discuss. 2005, 128, 13-27.
8. Lopez de la Paz, M.; Goldie, K.; Zurdo, J.; Lacroix, E.; Dobson, C. M.; Hoenger, A.; Serrano, L. De Novo Designed Peptide-Based Amyloid Fibrils. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16052-16057.
9. Lashuel, H. A.; LaBrenz, S. R.; Woo, L.; Serpell, L. C.; Kelly, J. W. Protofilaments, Filaments, Ribbons, and Fibrils from Peptidomimetic Self-Assembly: Implications for Amyloid Fibril Formation and Materials Science. J. Am. Chem. Soc. 2000, 122, 5262-5277.
10. Makin, O. S.; Atkins, E.; Sikorski, P.; Johansson, J.; Serpell, L. C. Molecular Basis for Amyloid Fibril Formation and Stability. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 315-320.
11. Fändrich, M.; Dobson, C. M. The Behavior of Polyamino Acids Reveals an Inverse Side Chain Effect in Amyloid Structure Formation. EMBO J. 2002, 21, 5682-5690.
12. Harper, J. D.; Lansbury, P. T. Models of Amyloid Seeding in Alzheimer's Disease and Scrapie: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins. Annu. Rev. Biochem. 1997, 66, 385-407.
13. Cohen, S. I. A.; Vendruscolo, M.; Dobson, C. M.; Knowles, T. P. J. From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation. J. Mol. Biol. 2012, 421, 160-171.
14. Dahlgren, K. N.; Manelli, A. M.; Stine, W. B.; Baker, J.; Lorinda, K.; Krafft, G. A.; LaDu, M. J. Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability. J. Biol. Chem. 2002, 277, 36046-36053.
15. Walsh, D. M.; Klyubin, I.; Fadeeva, J. V.; Cullen, W. K.; Anwyl, R.; Wolfe, M. S.; Rowan, M. J.; Selkoe, D. J. Naturally Secreted Oligomers of Amyloid-β Protein Potently Inhibit Hippocampal Long-Term Potentiation in Vivo. Nature 2002, 416, 535-539.
16. A˚slund, A.; Sigurdson, C. J.; Klingstedt, T.; Grathwohl, S.; Bolmont, T.; Dickstein, D. L.; Glimsdal, E.; Prokop, S.; Lindgren, M.; Konradsson, P.; Holtzman, D. M.; Hof, P. R.; Heppner, F. L.; Gandy, S.; Jucker, M.; Aguzzi, A.; Hammarström, P.; Nilsson, K. P. R. Novel Pentameric Thiophene Derivatives for in Vitro and in Vivo Optical Imaging of a Plethora of Protein Aggregates in Cerebral Amyloidoses. ACS Chem. Biol. 2009, 4, 673-684.
17. Foley, J.; Hill, S. E.; Miti, T.; Mulaj, M.; Ciesla, M.; Robeel, R.; Persichilli, C.; Raynes, R.; Westerheide, S.; Muschol, M. Structural Fingerprints and their Evolution during Oligomeric versus Oligomer-Free Amyloid Fibril Growth. J. Chem. Phys. 2013, 139, 121901/1-121901/12.
18. 2-Microglobulin into Amyloid. J. Mol. Biol. 2005, 351, 850-864.
19. Klein, W. L.; Krafft, G. A.; Finch, C. E. Targeting Small Aβ Oligomers: The Solution to an Alzheimer's Disease Conundrum? Trends Neurosci. 2001, 24, 219-224.
20. Stine, W. B., Jr.; Dahlgren, K. N.; Krafft, G. A.; LaDu, M. J. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis. J. Biol. Chem. 2003, 278, 11612-11622.
21. Uversky, V. N. Mysterious Oligomerization of the Amyloidogenic Proteins. FEBS J. 2010, 277, 2940-2953.
22. Cerf, E.; Sarroukh, R.; Tamamizu-Kato, S.; Breydo, L.; Derclaye, S.; Dufrêne, Y. F.; Narayanaswami, V.; Goormaghtigh, E.; Ruysschaert, J.-M.; Raussens, V. Antiparallel β-Sheet: A Signature Structure of the Oligomeric Amyloid β-Peptide. Biochem. J. 2009, 421, 415-423.
23. Zou, Y.; Li, Y.; Hao, W.; Hu, X.; Ma, G. Parallel β-Sheet Fibril and Antiparallel β-Sheet Oligomer: New Insights into Amyloid Formation of Hen Egg White Lysozyme under Heat and Acidic Condition from FTIR Spectroscopy. J. Phys. Chem. B 2013, 117, 4003-4013.
24. Stroud, J. C.; Liu, C.; Teng, P. K.; Eisenberg, D. Toxic Fibrillar Oligomers of Amyloid-β Have Cross-β Structure. Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 7717-7722.
25. Laganowsky, A.; Liu, C.; Sawaya, M. R.; Whitelegge, J. P.; Park, J.; Zhao, M.; Pensalfini, A.; Soriaga, A. B.; Landau, M.; Teng, P. K.; Cascio, D.; Glabe, C.; Eisenberg, D. Atomic View of a Toxic Amyloid Small Oligomer. Science 2012, 335, 1228-1231.
26. Jahn, T. R.; Radford, S. E. Folding versus Aggregation: Polypeptide Conformations on Competing Pathways. Arch. Biochem. Biophys. 2008, 469, 100-117.
27. Rhoades, E.; Gafni, A. Micelle Formation by a Fragment of Human Islet Amyloid Polypeptide. Biophys. J. 2003, 84, 3480-3487.
28. Hill, S. E.; Miti, T.; Richmond, T.; Muschol, M. Spatial Extent of Charge Repulsion Regulates Assembly Pathways for Lysozyme Amyloid Fibrils. PLoS One 2011, 6, e18171.1-e18171.12.
29. Yoshimura, Y.; Lin, Y.; Yagi, H.; Lee, Y.-H.; Kitayama, H.; Sakurai, K.; So, M.; Ogi, H.; Naiki, H.; Goto, Y. Distinguishing Crystal-Like Amyloid Fibrils and Glass-Like Amorphous Aggregates from Their Kinetics of Formation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 14446-14451.
30. Jung, J.-M.; Savin, G.; Pouzot, M.; Schmitt, C.; Mezzenga, R. Structure of Heat-Induced β-Lactoglobulin Aggregates and Their Complexes with Sodium-Dodecyl Sulfate. Biomacromolecules 2008, 9, 2477-2486.
31. Bolisetty, S.; Harnau, L.; Jung, J.-M.; Mezzenga, R. Gelation, Phase Behavior, and Dynamics of β-Lactoglobulin Amyloid Fibrils at Varying Concentrations and Ionic Strengths. Biomacromolecules 2012, 13, 3241-3252.
32. Kodali, R.; Wetzel, R. Polymorphism in the Intermediates and Products of Amyloid Assembly. Curr. Opin. Struct. Biol. 2007, 17, 48-57.
33. Krebs, M. R. H.; Wilkins, D. K.; Chung, E. W.; Pitkeathly, M. C.; Chamberlain, A. K.; Zurdo, J.; Robinson, C. V.; Dobson, C. M. Formation and Seeding of Amyloid Fibrils from Wild-Type Hen Lysozyme and a Peptide Fragment from the β-Domain. J. Mol. Biol. 2000, 300, 541-549.
34. Arnaudov, L. N.; de Vries, R. Thermally Induced Fibrillar Aggregation of Hen Egg White Lysozyme. Biophys. J. 2005, 88, 515-526.
35. Hill, S. E.; Robinson, J.; Matthews, G.; Muschol, M. Amyloid Protofibrils of Lysozyme Nucleate and Grow via Oligomer Fusion. Biophys. J. 2009, 96, 3781-3790.
36. Parmar, A. S.; Gottschall, P. E.; Muschol, M. Submicron Lysozyme Clusters Distort Kinetics of Crystal Nucleation in Supersaturated Lysozyme Solutions. Biophys. Chem. 2007, 129, 224-234.
37. Schmit, J. D.; Dill, K. A. The Stabilities of Protein Crystals. J. Phys. Chem. B 2010, 114, 4020-4027.
38. Kuehner, D. E.; Engmann, J.; Fergg, F.; Wernick, M.; Blanch, H. W.; Prausnitz, J. M. Lysozyme Net Charge and Ion Binding in Concentrated Aqueous Electrolyte Solutions. J. Phys. Chem. B 1999, 103, 1368-1374.
39. Schmit, J. D.; Whitelam, S.; Dill, K. Electrostatics and Aggregation: How Charge Can Turn a Crystal into a Gel. J. Chem. Phys. 2011, 135, 085103/1-085103/6.
40. Malmberg, C. G.; Maryott, A. A. Dielectric Constant of Water from 0-100 °C. J. Res. Natl. Bur. Stand. 1956, 56, 1-8.
41. Sasaki, S.; Asboe-Hansen, G. Serum and Urinary Lysozyme in Patients with Mastocytosis (Urticaria Pigmentosa), Systemic Scleroderma, and Psoriasis1. J. Invest. Dermatol. 1967, 49, 302-305.
42. Osserman, E. F.; Lawlor, D. P. Serum and Urinary Lysozyme (Muramidase) in Monocytic and Monomyelocytic Leukemia. J. Exp. Med. 1966, 124, 921-952.
43. Frare, E.; Polverino de Laureto, P.; Zurdo, J.; Dobson, C. M.; Fontana, A. A Highly Amyloidogenic Region of Hen Lysozyme. J. Mol. Biol. 2004, 340, 1153-1165.
44. Chamberlain, A. K.; Receveur, V.; Spencer, A.; Redfield, C.; Dobson, C. M. Characterization of the Structure and Dynamics of Amyloidogenic Variants of Human Lysozyme by NMR Spectroscopy. Protein Sci. 2001, 10, 2525-2530.
45. Fändrich, M. On the Structural Definition of Amyloid Fibrils and Other Polypeptide Aggregates. Cell. Mol. Life Sci. 2007, 64, 2066-2078.
46. Zandomeneghi, G.; Krebs, M. R. H.; McCammon, M. G.; Fändrich, M. FTIR Reveals Structural Differences between Native β-Sheet Proteins and Amyloid Fibrils. Protein Sci. 2004, 13, 3314-3321.
47. Lin, M. Y.; Lindsay, H. M.; Weitz, D. A.; Ball, R. C.; Klein, R.; Meakin, P. Universality in Colloid Aggregation. Nature 1989, 339, 360-362.
48. Mulaj, M.; Foley, J.; Muschol, M. Amyloid Oligomers and Protofibrils, but Not Filaments, Self-Replicate from Native Lysozyme. J. Am. Chem. Soc. 2014, 136, 8947-8956.
49. Apostol, M. I.; Perry, K.; Surewicz, W. K. Crystal Structure of a Human Prion Protein Fragment Reveals a Motif for Oligomer Formation. J. Am. Chem. Soc. 2013, 135, 10202-10205.
50. Lee, C. F. Isotropic-Nematic Phase Transition in Amyloid Fibrilization. Phys. Rev. E 2009, 80, 031902-031906.
51. Schmit, J. D.; Gosh, K.; Dill, K. Why Do Amyloid Molecules Assemble into Oligomers and Fibrils. Biophys. J. 2011, 100, 450-458.
52. Muschol, M.; Rosenberger, F. Liquid-Liquid Phase Separation in Supersaturated Lysozyme Solutions and Associated Precipitate Formation/Crystallization. J. Chem. Phys. 1997, 107, 1953-1962.
53. Hagen, M. H. J.; Frenkel, D. Determination of Phase-Diagrams for the Hard-Core Attractive Yukawa System. J. Chem. Phys. 1994, 101, 4093-4097.
54. Berland, C. R.; Thurston, G. M.; Kondo, M.; Broide, M. L.; Pande, J.; Ogun, O.; Benedek, G. B. Solid-Liquid Phase Boundaries of Lens Protein Solutions. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 1214-1218.
55. Auer, S.; Ricchiuto, P.; Kashchiev, D. Two-Step Nucleation of Amyloid Fibrils: Omnipresent or Not? J. Mol. Biol. 2012, 422, 723-730.
56. Jain, S.; Bates, F. S. On the Origins of Morphological Complexity in Block Copolymer Surfactants. Science 2003, 300, 460-464.
57. Jensen, G. V.; Lund, R.; Gummel, J.; Monkenbusch, M.; Narayanan, T.; Pedersen, J. S. Direct Observation of the Formation of Surfactant Micelles under Nonisothermal Conditions by Synchrotron SAXS. J. Am. Chem. Soc. 2013, 135, 7214-7222.